$Arcturus Therapeutics (ARCT.US)$
Arcturus宣佈自我放大 COVID-19 mRNA 生物-疫苗候選ARCt-154在第3期研究中達到主要效力端點。
https://finance.yahoo.com/news/arcturus-announces-self-amplifying-covid-113000171.html
Arcturus宣佈自我放大 COVID-19 mRNA 生物-疫苗候選ARCt-154在第3期研究中達到主要效力端點。
https://finance.yahoo.com/news/arcturus-announces-self-amplifying-covid-113000171.html
已翻譯
1
$強生 (JNJ.US)$
Dengue compound backed by J&J shows potency against the virus and all known variants in mice
https://www.fiercebiotech.com/research/dengue-pill-backed-by-j-j-shows-potency-against-virus-and-all-known-variants-mice
Dengue compound backed by J&J shows potency against the virus and all known variants in mice
https://www.fiercebiotech.com/research/dengue-pill-backed-by-j-j-shows-potency-against-virus-and-all-known-variants-mice
$Arcturus Therapeutics (ARCT.US)$Arcturus Announces Approval of a Clinical Trial Application to Advance ARCT-154, a Next Generation STARR™ mRNA Vaccine Targeting the SARS-CoV-2 Delta Variant and Other Variants of Concern
https://finance.yahoo.com/news/arcturus-announces-approval-clinical-trial-130000038.html
https://finance.yahoo.com/news/arcturus-announces-approval-clinical-trial-130000038.html
1
3
$Vir Biotechnology (VIR.US)$
Some preliminary positive results for sotrovimab
"The primary efficacy analysis of all 1,057 patients in the COMET-ICE trial demonstrated a 79% reduction (adjusted relative risk reduction) (p<0.001) in hospitalization for more than 24 hours or death due to any cause, by Day 29 compared to placebo, meeting the primary endpoint of the trial"
https://www.globenewswire.com/news-release/2021/06/21/2250117/0/en/GSK-and-Vir-Biotechnology-Announce-Continuing-Progress-of-the-COMET-Clinical-Development-Program-for-Sotrovimab.html
https://www.reuters.com/article/health-coronavirus-gsk-usa/study-confirms-gsk-vir-antibody-drug-reduces-hospitalization-death-in-covid-19-patients-idUSL3N2O32Q9...
Some preliminary positive results for sotrovimab
"The primary efficacy analysis of all 1,057 patients in the COMET-ICE trial demonstrated a 79% reduction (adjusted relative risk reduction) (p<0.001) in hospitalization for more than 24 hours or death due to any cause, by Day 29 compared to placebo, meeting the primary endpoint of the trial"
https://www.globenewswire.com/news-release/2021/06/21/2250117/0/en/GSK-and-Vir-Biotechnology-Announce-Continuing-Progress-of-the-COMET-Clinical-Development-Program-for-Sotrovimab.html
https://www.reuters.com/article/health-coronavirus-gsk-usa/study-confirms-gsk-vir-antibody-drug-reduces-hospitalization-death-in-covid-19-patients-idUSL3N2O32Q9...
2
$Arcturus Therapeutics (ARCT.US)$
02 June 2021
Primordial Genetics Grants Arcturus Therapeutics Exclusive License of an RNA Polymerase for Human and Animal Therapeutics
https://www.prnewswire.com/news-releases/primordial-genetics-grants-arcturus-therapeutics-exclusive-license-of-an-rna-polymerase-for-human-and-animal-therapeutics-301303621.html
02 June 2021
Primordial Genetics Grants Arcturus Therapeutics Exclusive License of an RNA Polymerase for Human and Animal Therapeutics
https://www.prnewswire.com/news-releases/primordial-genetics-grants-arcturus-therapeutics-exclusive-license-of-an-rna-polymerase-for-human-and-animal-therapeutics-301303621.html
$富途控股 (FUTU.US)$
The companies, FUTU AND TIGR, disclosed during earnings calls last month they are applying for licenses in Singapore and the U.S. that would allow local customers to trade digital currencies.
https://www.cnbc.com/2021/06/01/chinas-robinhood-rivals-pile-into-the-crypto-craze.html?recirc=taboolainternal
The companies, FUTU AND TIGR, disclosed during earnings calls last month they are applying for licenses in Singapore and the U.S. that would allow local customers to trade digital currencies.
https://www.cnbc.com/2021/06/01/chinas-robinhood-rivals-pile-into-the-crypto-craze.html?recirc=taboolainternal
$向上融科 (TIGR.US)$
這些公司在上個月收益通話中披露,他們正在新加坡和美國申請許可證,允許當地客戶交易數字貨幣。
https://www.cnbc.com/2021/06/01/chinas-robinhood-rivals-pile-into-the-crypto-craze.html?recirc=taboolainternal
這些公司在上個月收益通話中披露,他們正在新加坡和美國申請許可證,允許當地客戶交易數字貨幣。
https://www.cnbc.com/2021/06/01/chinas-robinhood-rivals-pile-into-the-crypto-craze.html?recirc=taboolainternal
已翻譯